Koers BioSig Technologies Inc Nasdaq
Aandelen
US09073N2018
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 100K 93,72K | Omzet 2025 * | 1 mln. 937K | Marktkapitalisatie | 18,59 mln. 17,42 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -6 mln. -5,62 mln. | Nettowinst (verlies) 2025 * | -12 mln. -11,25 mln. | EV/omzet 2024 * | 186 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 18,6 x |
K/w-verhouding 2024 * |
-2,21
x | K/w-verhouding 2025 * |
-1,28
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 81,19% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Frederick Hrkac
CEO | Chief Executive Officer | 58 | 27/02 |
Lora Mikolaitis
ADM | Chief Administrative Officer | 51 | 24-02-09 |
Chief Tech/Sci/R&D Officer | 74 | 24-02-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 74 | 24-02-09 | |
Frederick Hrkac
CEO | Chief Executive Officer | 58 | 27/02 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,15% | 217 mld. | |
+6,60% | 183 mld. | |
+9,86% | 131 mld. | |
+24,32% | 106 mld. | |
-0,95% | 62,16 mld. | |
+11,04% | 51,02 mld. | |
+4,81% | 50,89 mld. | |
-1,43% | 40,16 mld. | |
+24,40% | 31,44 mld. |